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COVID-19 Vaccine Uptake Through the Lived Experiences
of Health Care Personnel: Policy and Legal Considerations
Rachel Gur-Arie,1,*,i Zackary Berger,1–3 and Dorit Rubinstein Reiss4
Abstract
Purpose: To investigate whether coronavirus disease 2019 (COVID-19) vaccination campaigns targeted at health
care personnel (HCP) in the United States have addressed the lived experiences of HCP on the frontlines of the
COVID-19 pandemic and to analyze policy and legal considerations for improving COVID-19 vaccine uptake
among HCP.
Methods: We conducted a literature and policy review to explore the lived experiences of different occupational
groups of HCP on the frontlines of the COVID-19 pandemic—physicians, nurses, trainees, and nonclinical essential workers—in relation to ongoing COVID-19 vaccination campaigns. Finally, we discuss policy and legal considerations to improve the state of HCP COVID-19 vaccine uptake as the pandemic progresses.
Results: COVID-19 vaccination campaigns have not achieved consistent high uptake among HCP for many reasons, including vaccine hesitancy, personal, professional considerations, and equity-rooted challenges.
Conclusion: HCPs lived experiences during the COVID-19 pandemic reveal meaningful impediments to
their COVID-19 vaccine uptake. We suggest that health care systems minimize inequity inherent in existing vaccination campaigns by providing ﬁnancial and social support to HCP to raise HCP COVID-19
vaccine uptake.
Keywords: health care personnel; COVID-19; vaccine uptake; equity; ethics

Introduction
The coronavirus disease 2019 (COVID-19) pandemic
continues. Although multiple COVID-19 vaccines have
been approved and global vaccination is ongoing, inequity and vulnerability continue to pose a disproportionate burden to certain communities and health care
systems, despite vaccine rollout in many places.1,2 Many
COVID-19 vaccination campaigns are experiencing logistical and communication challenges, impeding the
speedy equitable distribution of available vaccines.3
Health care personnel (HCP), deﬁned by the Centers
for Disease Control and Prevention (CDC) in this context as ‘‘persons serving in health care settings who

have the potential for direct or indirect exposure to patients or infectious material,’’4 have been prioritized for
COVID-19 vaccination. This prioritization is reﬂected in multiple vaccine allocation plans developed by
public health professionals and bioethicists. According to the CDCs framework, prioritizing HCP for
COVID-19 allocation is rooted in three characteristics of this group1: they themselves are at high risk
for contracting COVID-19,2 they are doing essential
work during the pandemic, and3 they are a source of
COVID-19 transmission.4
As COVID-19 vaccination continues, discussion has
broadened beyond prioritization to access and uptake.
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Distributing COVID-19 vaccine among HCP is proving to be a signiﬁcant challenge, particularly in the
United States.5,6 HCP continue to work long hours in
under-resourced, overcrowded health care settings at
the frontlines of the COVID-19 pandemic.7 While immense psychological, physical, and mental burdens are
routine side effects of their profession, the emergency
nature of the pandemic has stretched them beyond
their limits.8 Multiple factors contribute to poor vaccine
uptake among HCPs. Their occupational experience
during COVID-19 is obviously signiﬁcant. Additionally,
documented vaccine hesitancy,9,10 decentralized health
care, and fragmented policies in states and other jurisdictions also contribute to low vaccine uptake.
There are little data on the uptake of COVID-19 vaccines among HCP by occupational group in the United
States. However, a study of COVID-19 vaccine uptake among more than 23,000 publicly employed HCP
in the United Kingdom found uptake rates of more
than 80% for all occupational groups.11 These occupational groups included administrative or executive
staff, nurses or health care assistants, doctors, midwives,
specialist staff, estates, porters, or security, pharmacists,
health care scientists, and ‘‘other.’’11 Given the United
Kingdom’s strong, centralized health care system (The
National Health Service12), these uptake rates should
not be extrapolated onto other contexts—particularly
the United States’ fragmented health care system.
The present analysis explores the legal and ethical
consequences of these selected variables to shed light
on potential directions for raising HCP COVID-19
vaccine uptake.
COVID-19 Lived Experiences Among HCP
HCP of varying disciplines have been pushed beyond
their physical and psychological limits during the
COVID-19 pandemic, suffering from heightened exhaustion, insomnia, tremendous workloads, weak institutional support, daily ethical dilemmas, depression,
anxiety, and, ultimately, burnout.13,14 Although these
symptoms cross occupational lines among HCP, experiences of COVID-19 within a given population, such
as HCP, are heterogeneous.15 Such nuances contribute to unique narratives, experiences, and vulnerabilities that should be recognized when implementing
COVID-19 vaccine campaigns for HCP.
Physicians
Physician leadership has guided the global ﬁght against
COVID-19 for over a year. Their lived experiences and
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challenges throughout COVID-19, characterized by
shortages of personal protective equipment (PPE), workforce, and institutional policies of ‘‘do not resuscitate’’
COVID-19 patients, have presented unprecedented
challenges that many have had to learn to manage in
real time.16 Death resulting from occupational infection of COVID-19 is the ultimate price that many physicians have paid; insufﬁcient PPE is frequently cited
as a contributor.17 This contributes to mistrust among
HCP in health care systems and institutions, which
they work for.
Before the COVID-19 pandemic, almost half of all
physicians were estimated to burnout, with higher
burnout rates documented for women.16,18 The heroization of physicians during COVID-19 has contributed
to a complicated public narrative in which physicians
may feel hesitant to speak up against poor working
conditions and response to the pandemic.19 But physician willingness to work in a pandemic is not without
limits. A study conducted in response to the 2009
swine ﬂu pandemic showed that only 25% of physicians
believed that there was a duty to work when the work
would pose risk to themselves or their family.20,21
While the prioritization of physicians to get vaccinated
against COVID-19 is important, poorly implemented
vaccination campaigns could quickly close the window
of opportunity to regain the trust lost among physicians in health care systems throughout the COVID-19
pandemic.
Nurses
Nurses spend the most one-on-one time with COVID-19
patients.13,22,23 As a result, nurses are often at increased
occupational risk for COVID-19 infection in comparison to other groups of HCP.22 During the COVID-19
pandemic, nurses have taken on leadership roles,
which are central to balancing staff and patient care,
and, as a result, added professional burden.24 A qualitative study of nurses in China, conducted early on
in the pandemic, suggested four themes that encompass nurses’ psychological experience during a peak
of COVID-19 infection and uncertainty1: a signiﬁcant number of negative emotions,2 varied coping
and self-care,3 growth under pressure, and4 positive
and negative emotions occurring simultaneously or progressively.23 Similar themes have been expressed within
an American context.24–27
Nurses navigate a spectrum of shifting priorities, personal and professional boundaries, and well-being.27
During the COVID-19 pandemic, it is not uncommon
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for nurses to cry or experience attacks on shift, while
feeling institutional pressure to stay quiet to stay employed.24 An additional deﬁning source of anxiety for
nurses during the COVID-19 pandemic, unique compared with other professions, is the fear that all nurses
will have to transform into intensive care unit nurses
due to stafﬁng shortages.28 The pandemic caused
nurses to experience consistently changing job duties
and increased overtime work; yet, nurses exhibited
professional solidarity, felt collective empowerment,
and activated psychological defense mechanisms.13
COVID-19 vaccination campaigns targeted at nurses
should be supportive, not punitive, cognizant of everpresent uncertainty and ampliﬁed burden that nurses
have been balancing during the pandemic.
Trainees
At the beginning of the pandemic, uncertainty dominated trainees’ present and future concerns: potential
redeployment to an unplanned department, cancellation of spring rotations, COVID-19 domination of
their rotation, burnout, cancellation of annual leave,
and concerns about lack of PPE, hot food, and available
resting places in the case of long shifts.29 Many trainees
experienced hopelessness and immense anxiety during
the COVID-19 pandemic.30 Supervision quality and
didactic learning have been disrupted by social distancing measures, whereas credentialing and examinations
have been delayed in many disciplines (e.g., radiology).31 Many trainees in their fourth year of medical
studies were called (by choice or by mandate) immediately to the frontlines during summer 2020 instead of
otherwise taking time off.32
Releasing HCP trainees to work beyond their established clinical or care competencies is a risk in itself
and worsens the ability to objectively evaluate the standardization, adequacy, and evidence-based nature of
their training during the COVID-19 pandemic.32 In the
United States, telemedicine dominates outpatient clinical
work, limiting experience with physical examinations, a
skill only mastered by practice.33 The disproportionate
burden placed on the generation of health professional
trainees during the COVID-19 pandemic, compared
with HCP trained during routine times, poses a significant threat to the future global health workforce.34
COVID-19 vaccination campaigns should recognize
this and not exclude trainees during vaccine rollout.
Nonclinical essential workers
Experiences of HCP performing clinical work have dominated headlines regarding HCP experiences on the front-
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lines of the COVID-19 pandemic. Yet, essential workers
within health care settings performing nonclinical duties,
often referred to as ‘‘support’’ or ‘‘ancillary staff,’’ have
been largely overlooked.35 Nonclinical essential workers
work in a variety of infrastructure roles within health
care, including, but not limited to: maintenance, janitorial,
and patient transport services, care assistants, and food
transport.35 In general, individuals from minority groups,
such as Black, Indigenous, and People of Color (BIPOC)
populations, are overrepresented across essential nonclinical roles in health care settings.35 BIPOC populations
have been hit the hardest in the United States by the
COVID-19 pandemic, testing positive and dying from
COVID-19 at a higher rate than other racial and ethnic
groups.36,37 Increased burdens of COVID-19 cases and
death are documented speciﬁcally among working people living in communities with high proportions of
people of color and additional social determinants of
health, such as poverty, economic segregation, and
crowded housing.38 Complexity surrounding understanding information regarding COVID-19 prevention, transmission, and infection is oftentimes
exacerbated by language barriers, health literacy, conﬂicting messaging, and mistrust.35,36,39,40
Additionally, nonclinical essential workers have had
inequitable access to PPE and COVID-19 testing in
comparison to their clinical counterparts.35 Testing
positive for COVID-19 as a nonclinical essential worker
from an underrepresented minority group also impacts their individual social needs as well as potentially
the social needs of their family, dependents, and community.35 Self-isolation may not be possible, and child
care may be unaffordable.35 Nonclinical essential workers should not continue to be overlooked as HCP
COVID-19 vaccine campaigns continue.
Challenges in COVID-19 Vaccine Uptake
Among HCP—Vaccine Hesitancy
Challenges to COVID-19 vaccine uptake among HCP
have long been anticipated, particularly in light of
established COVID-19 vaccine hesitancy among HCP,
a signiﬁcant contributor to vaccine uptake.9,41,42 Vaccine hesitancy exists on a spectrum, ranging from
‘‘ultimate refusers’’ (e.g., anti-vaccination movements)
to ‘‘ultimate acceptors’’ (e.g., getting vaccinated without
question, doubt), with the majority of people resting
somewhere in the middle. Vaccine hesitancy among
HCP is particularly unique given HCPs professional
duties to care and to ‘‘do no harm.’’43 From a public
health perspective, getting vaccinated as an HCP fulﬁlls
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both professional duties, and refusing vaccination (without a medical or value-based exemption44 could contradict, or not sufﬁciently fulﬁll, professional duties.
Factors contributing to vaccine hesitancy among
HCP include individual or social group inﬂuences
(i.e., vaccination as a social norm, perceived risk vs.
beneﬁt analysis), vaccine and vaccination-speciﬁc issues (i.e., vaccine effectiveness, vaccination incentives,
access, sufﬁcient training), and contextual inﬂuences
(i.e., religion, politics, history, socioeconomic status).45
Vaccine-refusing HCP are an uncommon but existent
minority group. A study investigating vaccine refusal
among HCP found that vaccine-refusing HCP have a
particularly negatively skewed risk perception against
vaccination (i.e., perceived high risk from vaccination
or low disease risk), decreased motivation to get vaccinated for the sake of others (i.e., perceived personal
and/or ﬁnancial cost disproportionate to the potential
beneﬁt of vaccination), and competing motivational
forces (i.e., deciding to act in the interest of protecting
oneself vs. caring for others, in light of respective perceived risk perceptions).46
COVID-19 vaccine hesitancy among HCP is emerging as vaccination campaigns continue. The fast-tracked
nature of COVID-19 vaccines, lacking transparency
and information, as well as concerns regarding the political climate in which the vaccine was developed
crossed all demographic groups of HCP, regardless of
sex, educational level, or ethnicity.47 Safety concerns,
questions of personal autonomy, and vaccine effectiveness skepticism arise in most cases of vaccine hesitancy.48,49 However, the unprecedented speed of
development of the vaccine, the emergency pandemic
backdrop, signiﬁcant remaining uncertainty surrounding the vaccine, and the fact that HCP are one of
the ﬁrst groups in the world to get vaccinated (potentially causing many to feel like ‘‘guinea pigs’’) make
HCP hesitancy toward the COVID-19 vaccine nontraditional. Additionally, 40% of HCP in the United
States, including both clinical and nonclinical essential workers, are people of color.50 Vaccine hesitancy
among people of color, particularly in the United
States, is an understandable, recognized result of structural systematic racism.51–53 Thus far, in the United
States, vaccine hesitancy is posing a signiﬁcant challenge to HCP uptake of the COVID-19 vaccine.54
To maximize the beneﬁt of prioritizing HCP to get
vaccinated against COVID-19, vaccination campaigns
should revisit the complexities of vaccine hesitancy
among HCP through engaging in discourse to adjust
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expectations, provide resources and support, and garner trust accordingly. After all, much vaccine hesitancy
coexists with barriers in access to getting vaccinated.
Challenges in COVID-19 Vaccine Uptake
Among HCP—Equity
A clear takeaway from COVID-19 vaccination campaigns across America and globally, regardless of their
success: the importance of equity.55 Within the United
States, access to COVID-19 vaccines and understanding of the process among HCP vary.56 At prestigious
health care settings, such as academic-afﬁliated hospitals, nonessential workers such as young researchers
and administrative staff not involved in patient care
have managed to get vaccinated over many frontline
HCP.57 Clear disparities emerged between HCP of the
same category but in different locations. For example,
certain medical students in the United States were
able to get vaccinated, whereas others working in different departments or locations were not.58
Information regarding COVID-19 vaccine rollout
among HCP may be limited to technological means
and in the English language, which prevents those
who struggle with technology and/or do not have a
consistent working smartphone or computer. These
struggles may be most prominent among older HCP
and nonclinical essential workers.59 As a result, they
are prevented from staying updated regarding their
COVID-19 vaccine access. In settings where confusion
and disorder dominates COVID-19 vaccination campaigns, privilege and connections can determine whether
or not one will manage to get vaccinated or not, even
among prioritized HCP.57 After all, in a setting where
HCP COVID-19 vaccine access is dependent on registering, as an employee, for a patient portal which they
have never used before, HCP may be hesitant to do so.
Health care systems and COVID-19 vaccination campaigns need to acknowledge the coexistence of these
factors, and ease HCPs access to COVID-19 vaccinations as much as possible.
Although COVID-19 vaccine uptake in the United
States among HCP according to occupational groups
is currently not widely available, Hall et al. found that
among publicly employed HCP in the United Kingdom, doctors had the highest COVID-19 vaccine uptake rate (92%), whereas estates, porters, or security
(for the purposes of this article, the equivalent of nonclinical essential workers) had the lowest COVID-19
vaccine uptake rate (82.9%).11 Nurses or health care assistants had a COVID-19 vaccine uptake rate of 87%.11

Gur-Arie, et al.; Health Equity 2021, 5.1
http://online.liebertpub.com/doi/10.1089/heq.2021.0027

Although medical students were not explicitly surveyed in the study, HCP younger than 25 years had a
COVID-19 vaccine rate of 83.9%.11 Uptake among
80% across all occupational groups is an accomplishment that most health care institutions in the United
States would probably celebrate, and although data
are currently unavailable, it may be unlikely to achieve,
given the gaps in access and decentralization of the
American health care system. Regardless, as expected, nonessential clinical workers have the lowest
COVID-19 vaccine uptake of the occupational groups.
This phenomenon is most likely to be expected across
all health care contexts, particularly in the United
States, and correlates with equity concerns raised here.
Various systematic interventions and avenues of
support could assist in raising COVID-19 vaccine
uptake among HCP. Mass vaccination events centrally
located in health care settings could create greater
awareness and participation in COVID-19 vaccination
among HCP, particularly as HCP are under increasing
time constraints and pressures as the pandemic continues.60 Given the little spare time that HCP have during their shifts, health care systems could provide
paid time off, overtime compensation, and childcare
to establish clearer access and ability for HCP to get
vaccinated against COVID-19.61 Nonclinical essential
workers in particular are generally nonunionized and
therefore have little to no organized ‘‘sway’’ in advocating for receiving such beneﬁts that would assist not
only their uptake of the COVID-19 vaccine but also
their health and well-being in general.62 As a result,
we urge health care systems and to take responsibility
for proper and equitable HCP access of COVID-19 vaccines within the workplace. This begins with supportive structural interventions, which reduce the burden
placed upon individual HCP to understand processes
related to COVID-19 vaccine access, from start to ﬁnish.
The COVID-19 experiences of HCP at the frontlines
of the pandemic are unprecedented, and COVID-19
vaccine rollout is an optimistic step toward the end
of the pandemic. Although COVID-19 vaccine hesitancy among HCP exists and is a substantial challenge
to COVID-19 vaccine uptake, access determines
whether vaccination is a tangible option. Inequities
can fuel vaccine hesitancy, particularly among vulnerable neglected populations.63 HCP are not immune to
inequitable COVID-19 vaccine access. COVID-19 vaccination campaigns should aim to minimize barriers to
access, particularly in light of HCPs COVID-19 lived
experiences.
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Determining HCP COVID-19 Vaccine Policy
COVID-19 vaccines are not the only vaccines recommended for HCP. The CDC recommends that HCP
get vaccinated against hepatitis B, inﬂuenza, varicella,
and meningococcal disease, as well as the MMR and
Tdap vaccines.64 Tools used to try and increase vaccination in the past included facilitating access, education, reminders, incentives, signed declination
statements, and mandates of different varieties.65 Experience with these tools in the contexts of other vaccines suggested that education and other support
programs, such as improving access and reminders,
increase uptake, but to a limited degree.65,66 However,
mandates tended to bring compliance to above
95%.65 COVID-19 vaccines funded by the U.S. government are, according to ofﬁcials, free to citizens, so free
vaccines may be less relevant, although facilitated
access may still be important.67
COVID-19 vaccines are different from these other
vaccines in several ways. First, the vaccines are authorized under an emergency use authorization (EUA),
not through the regular process.68 Second, these vaccines
use new technology,69 and although they went through
trials as large or larger than other vaccines, the speed
of the trials, combined with the new technology, could
cause concern in recipients. Third, the vaccines were authorized in the context of a pandemic, which means
both that the stakes were very high, and, as discussed,
that HCP were under substantial pressure and stress
for a lengthy time. And ﬁnally, there is not yet good
data that show that COVID-19 vaccines prevent transmission.70 Policy options that are justiﬁed when there
is strong evidence that vaccines prevent transmission
may not be justiﬁed when it is not.
The legal framework is similar across different HCP
groups previously discussed. The starting point is that
employers have extensive leeway to set employment conditions, with some caveats discussed below. In the context
of vaccines, traditionally, most health care facilities have
enforced uniform policies across the workforce, with
some differentiating between employees with patient contact and those without. However, we argue that different
policies may be suitable for different groups. Three factors
should be considered: risk (especially regarding patient
contact), ﬁnancial and status vulnerability, and emotional
vulnerability. Higher risk may support stronger policies;
but higher vulnerability suggests that supportive policies
are more appropriate than coercive ones.
Many health care systems across the world (e.g., in
Italy71) and institutions within the United States have
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implemented COVID-19 vaccine mandates for HCP.72
We agree with Mello et al.’s proposal that mandates
should be an option of last resort, adopted if, and
only if, a recommended and accessible vaccine’s voluntary uptake has fallen below the level required to
prevent spread.73 We would further argue that particularly for the more vulnerable populations especially
trainees and nonclinical essential workers, a mandate
should only be the last resort, with other tools prioritized as much as possible. Instead of implementing
hard mandates, where HCP would be terminated
from employment without getting vaccinated, employers should consider softer mandates—for example,
requiring HCP to wear extra PPE in the case they do
not get vaccinated against COVID-19—and incentives
to get vaccinated—for example, reduction in health
care premiums or time off.
Legal Consequences of COVID-19 Vaccine Policy
As long as distinctions in policies are not based on
protected categories, they are likely legal. Private employers are not subjected to constitutional requirements, but the Civil Rights Act of 1964 forbids
discrimination in employment based on race, gender,
or religion and may limit those categorizations here.
Public employers are subjected to the constitution,
including the equal protection clause, but criteria
based on categories that are not suspect—for example, based on whether one is a doctor or a resident
or a nonclinical employee—are subject to rational
basis review. Rational basis review simply requires a
reasonable basis for the distinction, linking it to a legitimate government interest—a low bar.74,75
That said, any policy with a degree of coercion may be
challenged in court, and likely will, and its vulnerability
to challenge needs to be considered. Policies focusing
on improving access or education, or even requiring
that a form be signed upon declining a COVID-19 vaccine, are unlikely to be challenged and have not been
challenged in the context of other vaccines. However,
mandates have been challenged in the context of other
vaccines and may well be challenged here, too.76,77 Mandates can be challenged in the context of a unionized
workforce if the requirements of collective bargaining
were not followed.76 As mentioned above, some groups
of workers—speciﬁcally, nonclinical workers—tend not
to be unionized, but other segments—such as nurses
and doctors—are often unionized. Mandates can also
be challenged under the Americans with Disabilities
Act if an employee with a qualifying disability alleges
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they did not receive the required accommodation.76
Mandates can be challenged on the grounds that an employee with sincere religious objections to the vaccine
was not provided reasonable accommodation, although
the bar for refusing accommodation for religious objections is lower.77
Current COVID-19 vaccines, authorized under an
EUA only, may face another type of legal challenge.
It is unclear whether employers can legally mandate a
vaccine under an EUA. The statutory language not
only talks about informing individuals that they have
the option to refuse or accept a vaccine but also talks
about the possibility that individuals will face consequences for such refusal.78 The fact that the vaccine
is not yet fully approved may make it experimental,
and there is an argument that experimental products
cannot be required. However, the vaccines are authorized for use by the U.S. Food and Drug Administration (FDA), and traditionally, employers may set
work conditions. The EUA statute says nothing about
employers or states—it does not explicitly limit the
power to require a vaccine. Reading into this vague language, a prohibition for employers to do something
employers, traditionally, could legally do (i.e., mandate
vaccines), is reading a lot into the text. This is an area
of uncertainty, although employers are acting on the
assumption that they can mandate these vaccines,
and may have good grounds. Before COVID-19 vaccines, the only previous EUA for a vaccine was in
2005, for an anthrax vaccine for the military only—
and the military faces a different legal environment
than the general population. There are, therefore, no
cases on point, although we likely will see cases emerging from the COVID-19 pandemic.
On December 16, 2020, the Equal Employment
Opportunity Commission (EEOC) issued guidance related to COVID-19 vaccines.79 The guidance made it
clear that the EEOC was treating COVID-19 vaccines
similarly to other vaccines and mentioned only that
the FDA has an obligation to inform recipients about
the option to refuse the vaccines and consequences.79
Employers mandating COVID-19 vaccines may face
legal challenges, but the risk is likely not higher than
for other vaccines mandates, and in the health care settings, those often survive scrutiny. Areas employers
should be mindful of are the need to negotiate with
any unions that represent their workforce, and the
need to make available accommodations to those
with sincere religious objections or qualifying disabilities, unless accommodating is too high a burden.
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Conclusions
Raising COVID-19 vaccine uptake among HCP has
been challenging for a variety of reasons, including
confusing distribution campaigns, vaccine hesitancy,
and inequity. This analysis evaluated the existing
challenges to the implementation of COVID-19 vaccination among different occupational groups of HCP—
physicians, nurses, trainees, and nonclinical essential
workers—through their lived experiences at the frontlines of the pandemic. To raise COVID-19 vaccine uptake among HCP, health care systems should focus on
minimizing inequities inherent in existing campaigns.
We suggest that the health care systems and vaccination campaigns provide ﬁnancial and social support
to offset respective burdens.
There are a variety of COVID-19 vaccine policy
options targeted to HCP to consider, ranging from
recommendations to mandates. COVID-19 vaccine
policy making is unique for many reasons, and we
argue that mandates should be the last resort for
COVID-19 vaccine policy among HCP insofar as all
other interventions have been employed. Policymakers should consider involving HCP in the process
to provide representation in the decision-making process. After all, HCP have been the backbone of the
global response to COVID-19. Vaccinating them
against COVID-19 is the ethical duty of health care
systems. Health care institutions should recognize
the lived experiences of different occupational groups
HCP on the frontlines of the pandemic as they further
target HCP in COVID-19 vaccination campaigns by
improved implementation, which recognizes that
not all HCP are alike.
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